Newpath Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Kojin TherapeuticsinJun 2021SEC filingmedium confidence
BiotechBoston, US
Nagesh Mahanthappa, Ph.D.(Director)Luba Greenwood(Director)
BoardAmir Nashat, Ph.D.(Treasurer and Secretary)Susan Langer(President)
Board seatThomas J. Cahill· per SEC Form D · $60.2M raise · filed Jun 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.